Phreesia Q4 Fiscal 2026 Financial Review
Company Overview Phreesia, Inc. provides digital patient activation solutions, including tools for intake, outreach, and education, to enhance the patient...
Company Overview Phreesia, Inc. provides digital patient activation solutions, including tools for intake, outreach, and education, to enhance the patient...
Company Overview HireQuest is a national franchisor offering on-demand staffing and executive search services across multiple industries. Key Financial Figures...
NIKE, Inc. (NYSE: NKE) reported revenues of $11.3 billion for the third quarter of 2026, flat on a reported basis...
Mixed Quarter. Americas Gold and Silver Corporation (AMEX:USAS) delivered a challenging Q4 2025, posting an adjusted loss of $0.13 per…
Company Overview LM Funding America, Inc. is a Florida-based Bitcoin treasury and mining firm. The company also operates a specialty...
Company Overview Satellos Bioscience Inc. (NASDAQ: MSLE) is a clinical-stage biotechnology company focused on developing SAT-3247 to treat degenerative muscle...
Company Overview Entera Bio is a clinical-stage leader developing oral peptide therapies, specifically focusing on its N-TabĀ® platform. Its lead...
Company Overview Monopar Therapeutics is a clinical-stage biopharmaceutical company developing treatments for Wilson disease and advanced cancers. Key Financial Figures...
Company Overview Instil Bio is a biotechnology firm focused on advancing innovative therapeutics. The company recently discontinued the clinical development...
Narrower Loss. PDS Biotechnology Corporation (NASDAQ:PDSB) reported a Q4 2025 loss per share of -$0.74, reflecting a 28.2% improvement from…